APIA, Samoa, Oct. 13, 2025 /PRNewswire/ — Phemex, the most efficient crypto exchange, announced its Halloween Futures Trading Festival, offering 200,000 USDT in rewards for traders participating between October 10 and October 31, 2025. The campaign is open to both first-time and experienced futures traders.
The festival includes:
First Futures Trade Reward — Users completing their first futures trade of 100 USDT or more receive a 200 USDT futures position voucher.
Volume-Based Milestone Pool — A 70,000 USDT reward structure distributed across five trading volume tiers.
Registration is open through October 31 at 10:00 UTC. Full details are available at the event landing page.
The festival is part of Phemex’s seasonal trading initiatives for October 2025.
About Phemex
Founded in 2019, Phemex is the most efficient crypto exchange trusted by over 6 million traders worldwide. The platform offers spot and derivatives trading, copy trading, and wealth management products that combine seamless functionality with institutional-grade security. Known for its reliability and innovative edge, Phemex stands out for prioritizing user experience and transparency in an industry where trust is essential.
For more information, please visit: https://phemex.com/
Photo – https://mma.prnewswire.com/media/2794608/1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/phemex-announces-halloween-futures-trading-festival-with-200-000-usdt-prize-pool-302581999.html
New Axi Select series features traders and market professionals discussing strategy, risk management, and global…
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 25, 2026…
MAVAN will be the largest Ethereum staking service provider globally and will provide staking services…
LONDON, March 25, 2026 /PRNewswire/ -- Wahed, the world's leading Islamic fintech welcomes Noussair Mazraoui…
SHANGHAI, March 25, 2026 /PRNewswire/ -- SANY recently held a product launch event themed "Usher…
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the…